Evaluating the effectiveness of nicardipine prolonged-release implants in patients with subarachnoid hemorrhage: a meta-analysis and meta-regression analysis.

Ann Med Surg (Lond) · 2025 · PMC11981271 · PMID 40212151

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The pooled risk ratio was 2.03 (95% CI: 0.85–4.87, P = 0.11), suggesting a trend toward improved functional outcomes with nicardipine implants, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.